WELL Cost Of Revenue from 2010 to 2024

WELL Stock  CAD 7.02  0.02  0.29%   
WELL Health Cost Of Revenue yearly trend continues to be very stable with very little volatility. Cost Of Revenue is likely to grow to about 487.8 M this year. During the period from 2010 to 2024, WELL Health Cost Of Revenue quarterly data regression pattern had sample variance of 29495.9 T and median of  286,553. View All Fundamentals
 
Cost Of Revenue  
First Reported
2016-03-31
Previous Quarter
129.3 M
Current Value
153.1 M
Quarterly Volatility
46.8 M
 
Yuan Drop
 
Covid
Check WELL Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among WELL Health's main balance sheet or income statement drivers, such as Interest Expense of 32.9 M, Selling General Administrative of 223.3 M or Other Operating Expenses of 771.7 M, as well as many indicators such as Price To Sales Ratio of 1.11, Dividend Yield of 0.0 or PTB Ratio of 1.23. WELL financial statements analysis is a perfect complement when working with WELL Health Valuation or Volatility modules.
  
This module can also supplement various WELL Health Technical models . Check out the analysis of WELL Health Correlation against competitors.

Other Information on Investing in WELL Stock

WELL Health financial ratios help investors to determine whether WELL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WELL with respect to the benefits of owning WELL Health security.